Donald A Kalkofen Net Worth & Insider Trades

Donald A Kalkofen - Chief Financial Officer, Protagonist Therapeutics, Inc

As of February 17, 2022

What is Donald A Kalkofen's Net Worth?

The current estimated net worth of Protagonist Therapeutics, Inc's Chief Financial Officer, Donald A Kalkofen, is estimated to be about $10.5K . Donald A Kalkofen owns about 1,175 units of Protagonist Therapeutics, Inc common stock. In the last 3 years at Protagonist Therapeutics, Inc, Donald A Kalkofen has sold an estimated value of $0 worth.

What is Donald A Kalkofen's Past Insider Trading?

Donald A Kalkofen's largest purchase order was 1,175 units , worth over $5.99K on December 3, 2019. In total, Donald A Kalkofen has made about 5 transactions over 3 years of their time at Protagonist Therapeutics, Inc. Donald A Kalkofen usually trades in February, with the busiest year in 2019.

Donald A Kalkofen

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Donald A Kalkofen's' Mailing Address?

  • Mailing address is 7707 Gateway Boulevard, Suite 140 Newark CA 94560 CA

Protagonist Therapeutics, Inc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Dinesh V. Patel, Ph.D. 2020 $565,000 - $1,183,155 $473,894 $3,573 $2,225,622
Dinesh V. Patel, Ph.D. 2019 $545,000 $230,575 $814,355 $354,250 $4,164 $1,948,344
David Y. Liu, Ph.D. 2020 $441,300 - $352,429 $266,987 $11,133 $1,071,849
David Y. Liu, Ph.D. 2019 $428,450 $120,300 $424,881 $218,509 $7,458 $1,199,598
Suneel Gupta, Ph.D. 2020 $420,000 - $427,950 $256,200 $4,120 $1,108,270
Suneel Gupta, Ph.D. 2019 $377,467 $60,150 $693,789 $196,767 $3,564 $1,331,737
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1377121/000110465921050202/tm212463-1_def14a.htm

What are Protagonist Therapeutics, Inc's Past Insider Trades?

Protagonist Therapeutics, Inc's most recent insider trade came on December 23, 2021 by Dinesh V. Patel Ph.D. who sold 15,000 units worth $482.17K . In the last 5 years, insiders at Protagonist Therapeutics, Inc have sold an estimated value of $7.47M and bought an estimated value of $37.1M worth of shares. Insider trading is most common in May, with the busiest year in 2018. The most active traders at the company are Dinesh V. Patel, Ph.D., President and CEO,  David yLiu, Chief R&D Strategy Officer,  and Harold E Selick, Director .

Protagonist Therapeutics, Inc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1